M. S. Wallace, MD, “A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008—a long-acting, parenteral opioid analgesic—in the treatment of postherpetic neuralgia”, J of Opioid Management, vol. 2, no. 3, pp. 167–173, May 2006.